Page last updated: 2024-10-26

etanidazole and Infarction, Middle Cerebral Artery

etanidazole has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research Excerpts

ExcerptRelevanceReference
"Mice were subjected to filament-induced middle cerebral artery occlusion for 2 hours."1.35Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia. ( Marti, HH; Sun, L; Veltkamp, R, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, L1
Marti, HH1
Veltkamp, R1

Other Studies

1 other study available for etanidazole and Infarction, Middle Cerebral Artery

ArticleYear
Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia.
    Stroke, 2008, Volume: 39, Issue:3

    Topics: Animals; Brain; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Down-Regulation; Etanidazole; Fluo

2008